TRDA.NASDAQEntrada Therapeutics, INC

Form 4: Entrada Therapeutics' President & COO Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing

📋All filings for Entrada Therapeutics, INC
🔒Login to Follow

Nathan J. Dowden, President & COO of Entrada Therapeutics, sold shares of common stock between September 3rd and September 5th, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • Nathan J. Dowden, the President & COO of Entrada Therapeutics, Inc. (TRDA), reported the sale of common stock to cover tax obligations.
  • The sales occurred between September 3rd and September 5th, 2024.
  • The transactions were not discretionary trades but were mandated by a sell-to-cover provision in the award agreement.
  • A total of 1,808 shares were sold across the three days at weighted average prices ranging from $15.126 to $17.702.
  • Following these transactions, Dowden still beneficially owns 128,299 shares of Entrada Therapeutics common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales to cover tax obligations, which is a common practice. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Key Dates

DateDescription
09/03/2024First reported transaction date; sale of common stock.
09/04/2024Second reported transaction date; sale of common stock.
09/05/2024Third reported transaction date; sale of common stock and date of signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.